GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (OTCPK:SEMHF) » Definitions » Debt-to-Equity

Siemens Healthineers AG (Siemens Healthineers AG) Debt-to-Equity : 0.04 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Debt-to-Equity?

Siemens Healthineers AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $232 Mil. Siemens Healthineers AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $498 Mil. Siemens Healthineers AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $19,446 Mil. Siemens Healthineers AG's debt to equity for the quarter that ended in Dec. 2023 was 0.04.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Siemens Healthineers AG's Debt-to-Equity or its related term are showing as below:

SEMHF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.04   Max: 0.06
Current: 0.04

During the past 9 years, the highest Debt-to-Equity Ratio of Siemens Healthineers AG was 0.06. The lowest was 0.01. And the median was 0.04.

SEMHF's Debt-to-Equity is ranked better than
84.13% of 712 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs SEMHF: 0.04

Siemens Healthineers AG Debt-to-Equity Historical Data

The historical data trend for Siemens Healthineers AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Debt-to-Equity Chart

Siemens Healthineers AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only 0.01 0.04 0.04 0.04 0.04

Siemens Healthineers AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.04 0.04

Competitive Comparison of Siemens Healthineers AG's Debt-to-Equity

For the Medical Devices subindustry, Siemens Healthineers AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Siemens Healthineers AG's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Debt-to-Equity falls into.


Siemens Healthineers AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Siemens Healthineers AG's Debt to Equity Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(210.245 + 465.315) / 19296.692
=0.04

Siemens Healthineers AG's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(232.279 + 498.364) / 19446.02
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siemens Healthineers AG  (OTCPK:SEMHF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Siemens Healthineers AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Siemens Healthineers AG (Siemens Healthineers AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (OTCPK:SEMHF) » Definitions » Debt-to-Equity
Comparable Companies
LSE:SN. LSE:NIOX LSE:MXCT LSE:EKF LSE:CREO LSE:BELL LSE:IUG LSE:IHC LSE:POLX LSE:SUN ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
SMMNY:USA 1SHL:Italy SHLd:UK SHL1:Germany SHL:Germany SHL:Germany SHL:Germany SHL:Germany SHL:Austria
Address
Siemensstr. 3, Forchheim, BY, DEU, 91301
Website
https://www.siemens-healthineers.com
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.